Gene-expression profiles predict survival of patients with lung adenocarcinoma
- PMID: 12118244
- DOI: 10.1038/nm733
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Abstract
Histopathology is insufficient to predict disease progression and clinical outcome in lung adenocarcinoma. Here we show that gene-expression profiles based on microarray analysis can be used to predict patient survival in early-stage lung adenocarcinomas. Genes most related to survival were identified with univariate Cox analysis. Using either two equivalent but independent training and testing sets, or 'leave-one-out' cross-validation analysis with all tumors, a risk index based on the top 50 genes identified low-risk and high-risk stage I lung adenocarcinomas, which differed significantly with respect to survival. This risk index was then validated using an independent sample of lung adenocarcinomas that predicted high- and low-risk groups. This index included genes not previously associated with survival. The identification of a set of genes that predict survival in early-stage lung adenocarcinoma allows delineation of a high-risk group that may benefit from adjuvant therapy.
Similar articles
-
Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS wild-type lung adenocarcinoma reveals gene signatures associated with patient outcome.Clin Cancer Res. 2013 Sep 15;19(18):5116-26. doi: 10.1158/1078-0432.CCR-13-0928. Epub 2013 Aug 12. Clin Cancer Res. 2013. PMID: 23938291
-
A prognostic test for adenocarcinoma of the lung from gene expression profiling data.Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):905-10. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504202
-
Identification of early-stage lung adenocarcinoma prognostic signatures based on statistical modeling.Cancer Biomark. 2017;18(2):117-123. doi: 10.3233/CBM-151368. Cancer Biomark. 2017. PMID: 27935544
-
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.J Clin Oncol. 2006 Nov 1;24(31):5079-90. doi: 10.1200/JCO.2005.05.1748. J Clin Oncol. 2006. PMID: 17075127 Review.
-
Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.J Clin Oncol. 2008 Feb 20;26(6):877-83. doi: 10.1200/JCO.2007.13.1516. J Clin Oncol. 2008. PMID: 18281660
Cited by
-
Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.Theranostics. 2020 Sep 14;10(24):11264-11277. doi: 10.7150/thno.47039. eCollection 2020. Theranostics. 2020. PMID: 33042282 Free PMC article.
-
Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.Cancer Res. 2013 Jul 1;73(13):3821-32. doi: 10.1158/0008-5472.CAN-13-0031. Epub 2013 May 2. Cancer Res. 2013. PMID: 23639940 Free PMC article.
-
BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation.Sci Rep. 2022 Sep 29;12(1):16310. doi: 10.1038/s41598-022-20788-2. Sci Rep. 2022. PMID: 36175474 Free PMC article.
-
mRMR-ABC: A Hybrid Gene Selection Algorithm for Cancer Classification Using Microarray Gene Expression Profiling.Biomed Res Int. 2015;2015:604910. doi: 10.1155/2015/604910. Epub 2015 Apr 15. Biomed Res Int. 2015. PMID: 25961028 Free PMC article.
-
Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer.Ann Surg. 2013 Mar;257(3):548-54. doi: 10.1097/SLA.0b013e31826d81fd. Ann Surg. 2013. PMID: 23011390 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases